Concomitantly, CD4+ T cells shape tumour immune responses at the tumour site and in lymphoid organs either by supporting cancer cell elimination (T helper cells or Th, follicular helper T cells and CD4+ CTLs) or by promoting an immunosuppressing TME and tumour growth (mainly CD4+ regulatory T cells or Treg cells) [264]. This evidence concerns the gene CD4 and cancer.